Back

Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Adipose tissue, metabolic syndrome, and cardiometabolic disease Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Walaa Fakih

University of Strasbourg, Strasbourg (France)

5 More presentations in this session

Presentation thumbnail
Inflammatory epicardial adipose tissue–myocardial crosstalk in coronary artery disease: a single-cell analysis
Doctor S. Doppler (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Transcriptomic profiling of dysfunctional adipose tissue defines biomarker signatures that improve diabetes risk assessment
Doctor O. Brown (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Cilostazol restores endothelial function and reduces platelet hyperactivity via PKA/ENOS/PKG and NRF2 signaling in experimental metabolic syndrome
Doctor G. Lima (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank
Mr R. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Skeletal muscle acts as a major organ for systemic oxidized LDL clearance via a CD36-dependent mechanism enhanced by physical exercise.
Professor T. Sawamura (Matsumoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Adipose tissue, metabolic syndrome, and cardiometabolic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue Glucagon-like peptide-1 receptor upregulation in human atrial fibrillation might be functionally offset by accompanying Phosphodiesterase-4 upregulation
29 August 2026
thumbnail
Congress Presentation
GLP-1 receptor agonists and risk of early and late recurrence after AF ablation in type 2 diabetes: an analysis from a global federated research network
29 August 2026
thumbnail
Congress Presentation
The impact of atrial fibrillation progression on the epicardial adipose tissue volume: supporting 'AF begets EAT' theory
29 August 2025
thumbnail
Congress Presentation
FPR2 agonists exert cardioprotection by resolving inflammatory signalling in macrophages, not cardiomyocytes or cardiac fibroblasts
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources